Xilio Therapeutics (XLO) Operating Income Growth (5y) (2025 - 2026)

Xilio Therapeutics (XLO) Operating Income Growth (5y) (2025 - 2026) Analysis & Trends

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)
1	Nanobiotix	1,785.11 Bn	1,785.05 Bn	-
2	Akari Therapeutics	1,009.43 Bn	1,009.43 Bn	-
3	BeOne Medicines	473.57 Bn	468.78 Bn	1.35 Bn
4	Vertex Pharmaceuticals	123.78 Bn	116.54 Bn	2.59 Bn
5	Regeneron Pharmaceuticals	71.73 Bn	62.98 Bn	3.31 Bn
6	Belite Bio	62.12 Bn	62.12 Bn	-
7	Argenx Se	54.64 Bn	49.45 Bn	1.41 Bn
8	Alnylam Pharmaceuticals	38.05 Bn	35.05 Bn	959.66 Mn
9	Revolution Medicines	36.28 Bn	36.28 Bn	-
10	Xilio Therapeutics	148.07 Mn	-2.23 Mn	-

Download Data